[go: up one dir, main page]

BG28847A3 - METHOD FOR OBTAINING HYDANTOIN DERIVATIVES - Google Patents

METHOD FOR OBTAINING HYDANTOIN DERIVATIVES

Info

Publication number
BG28847A3
BG28847A3 BG037604A BG3760477A BG28847A3 BG 28847 A3 BG28847 A3 BG 28847A3 BG 037604 A BG037604 A BG 037604A BG 3760477 A BG3760477 A BG 3760477A BG 28847 A3 BG28847 A3 BG 28847A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
hydantoin derivatives
hydantoin
derivatives
proven
Prior art date
Application number
BG037604A
Other languages
Bulgarian (bg)
Inventor
Reinhard Sarges
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG28847A3 publication Critical patent/BG28847A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Метод за получаване на охарактеризирани и доказани в описанието хидантоинови производни с формула..... Патентните претенции са формулирани в 22 точки.Method for obtaining characterized and proven in the description hydantoin derivatives with formula..... The patent claims are formulated in 22 points.

BG037604A 1976-10-18 1977-10-18 METHOD FOR OBTAINING HYDANTOIN DERIVATIVES BG28847A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
BG28847A3 true BG28847A3 (en) 1980-07-15

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
BG037604A BG28847A3 (en) 1976-10-18 1977-10-18 METHOD FOR OBTAINING HYDANTOIN DERIVATIVES

Country Status (29)

Country Link
JP (3) JPS5353653A (en)
AR (1) AR220901A1 (en)
AT (1) AT356136B (en)
AU (1) AU504978B2 (en)
BG (1) BG28847A3 (en)
CA (1) CA1088945A (en)
CH (1) CH625511A5 (en)
DD (1) DD131931A5 (en)
DE (4) DE2746244C2 (en)
DK (1) DK150302C (en)
ES (1) ES463267A1 (en)
FI (1) FI62307C (en)
FR (1) FR2367754A1 (en)
GB (1) GB1566171A (en)
GR (1) GR70201B (en)
HK (1) HK53881A (en)
IE (1) IE45805B1 (en)
IL (1) IL53094A0 (en)
KE (1) KE3167A (en)
LU (1) LU78330A1 (en)
MX (1) MX4899E (en)
MY (1) MY8200157A (en)
NL (1) NL167434C (en)
NO (1) NO148453C (en)
NZ (1) NZ185358A (en)
PH (1) PH15639A (en)
PT (1) PT67164B (en)
SE (1) SE437024B (en)
YU (1) YU40821B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (en) * 1982-01-20 1983-12-12 Eisai Co Ltd Remedy containing hydantoin derivative
JPS59500617A (en) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド Hydantoin therapeutic agent
SU1380610A3 (en) * 1982-12-06 1988-03-07 Пфайзер Инк. (Фирма) Method of producing spiroheteroazolydindiones or pharmaceutically acceptable salts thereof
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (en) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk Novel spiro-3-heteroazolidine compound, production thereof, preventive and remedy for diabetic complication comprising same as active ingredient
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (en) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd Hydantoin derivative, salt and, production thereof and preventing and treating, agent for diabetic complication
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
JP2005523314A (en) 2002-04-18 2005-08-04 ユニバーシティ オブ バージニア パテント ファウンデーション Novel sodium channel blocking compounds
FR2955107B1 (en) 2010-01-08 2012-03-02 Servier Lab NOVEL THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (en) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Process for the production of new, anticonvulsant spirohydantoins
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (en) * 1974-10-11 1976-05-20 Schering Ag NEW PYRIDINE DERIVATIVES
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
JPS5534132B2 (en) 1980-09-04
NL167434C (en) 1981-12-16
KE3167A (en) 1981-11-06
LU78330A1 (en) 1979-06-01
HK53881A (en) 1981-11-13
IE45805L (en) 1978-04-18
DK461377A (en) 1978-04-19
DE2746244A1 (en) 1978-04-20
PT67164B (en) 1979-03-20
ATA745977A (en) 1979-09-15
NO148453B (en) 1983-07-04
DK150302C (en) 1987-09-28
IE45805B1 (en) 1982-12-01
FI62307B (en) 1982-08-31
FI62307C (en) 1982-12-10
IL53094A0 (en) 1977-12-30
NO773548L (en) 1978-04-19
PT67164A (en) 1977-11-01
CH625511A5 (en) 1981-09-30
NO148453C (en) 1983-10-12
DE2759543C2 (en) 1987-04-09
PH15639A (en) 1983-03-11
FR2367754B1 (en) 1982-07-09
JPS5495570A (en) 1979-07-28
SE7711053L (en) 1978-04-19
DE2759542C2 (en) 1988-07-07
DE2759927C2 (en) 1986-12-04
JPS5940388B2 (en) 1984-09-29
MY8200157A (en) 1982-12-31
JPS5353653A (en) 1978-05-16
AU504978B2 (en) 1979-11-01
FI773060A7 (en) 1978-04-19
NL7711358A (en) 1978-04-20
AT356136B (en) 1980-04-10
CA1088945A (en) 1980-11-04
DD131931A5 (en) 1978-08-09
AR220901A1 (en) 1980-12-15
JPS5495575A (en) 1979-07-28
ES463267A1 (en) 1978-07-16
SE437024B (en) 1985-02-04
GR70201B (en) 1982-08-31
YU40821B (en) 1986-06-30
AU2943177A (en) 1979-04-12
JPS607997B2 (en) 1985-02-28
DK150302B (en) 1987-02-02
FR2367754A1 (en) 1978-05-12
NL167434B (en) 1981-07-16
MX4899E (en) 1982-12-14
NZ185358A (en) 1979-06-08
GB1566171A (en) 1980-04-30
DE2746244C2 (en) 1983-05-19
YU244277A (en) 1982-08-31

Similar Documents

Publication Publication Date Title
BG38164A3 (en) METHOD FOR OBTAINING N- SUBSTITUTED-4-PIPERIDANAMINES
BG34340A3 (en) METHOD FOR OBTAINING COMPOUNDS C-076 AND THEIR DERIVATIVES
BG37375A3 (en) METHOD FOR OBTAINING PROLINE DERIVATIVES
BG28708A3 (en) METHOD FOR OBTAINING IMIDAZOLE DERIVATIVES
BG31225A3 (en) METHOD FOR OBTAINING ACYLANILIDE DERIVATIVES
BG28847A3 (en) METHOD FOR OBTAINING HYDANTOIN DERIVATIVES
BG31499A3 (en) METHOD FOR OBTAINING 1-VINYLTRIAZOLE DERIVATIVES
BG32115A4 (en) METHOD FOR OBTAINING HYDANTOINS
BG35327A3 (en) METHOD FOR OBTAINING PYRIDOXINE DERIVATIVES
BG36044A3 (en) METHOD FOR OBTAINING PIPERAZINE DERIVATIVES
BG31377A3 (en) METHOD FOR OBTAINING PHENYLETHYLAMINES
BG32268A3 (en) METHOD FOR OBTAINING IMIDAZOLE DERIVATIVES
BG28573A3 (en) METHOD FOR OBTAINING AMINOALKOXYPHENYL DERIVATIVES
BG28849A3 (en) METHOD OF OBTAINING GAMAPYRONES
BG35039A3 (en) METHOD FOR PREPARING SUBSTITUTED HETEROCYCLIC PHENOXYAMINES
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG35464A3 (en) Method preparing fluorene derivatives
BG33292A3 (en) METHOD FOR OBTAINING PENAMSULFOXIDE DERIVATIVES
BG31073A3 (en) METHOD FOR PREPARATION OF 1,5-SUBSTITUTED-2-PYRROLIDONES
BG36631A3 (en) METHOD FOR OBTAINING SULFUR-CONTAINING ISOQUINOLINE DERIVATIVES
BG37994A3 (en) METHOD FOR OBTAINING TETRAHYDROQUINOLINE DERIVATIVES
BG32117A4 (en) METHOD OF OBTAINING OLEANDOMYCINS
BG28264A3 (en) METHOD OF OBTAINING CORTICOIDS
BG28845A3 (en) METHOD FOR PREPARING N-ALKYLDIPHENYLAMINES
BG27897A3 (en) METHOD FOR OBTAINING BENZO(C)QUINOLINES